Treatment of Stage II-III Rectal Cancer Patients

被引：10

作者：

Kim, Miranda B. ^{[1
]}

Hong, Theodore S. ^{[1
]}

Wo, Jennifer Y. ^{[1
]}

机构：

[1] Massachusetts Gen Hosp, Boston, MA 02114 USA

来源：

CURRENT ONCOLOGY REPORTS | 2014年 / 16卷 / 01期

关键词：

Radiation therapy; Node-positive rectal cancer; Preoperative chemotherapy; Postoperative chemotherapy; Rectal cancer; Colorectal cancer; POSTOPERATIVE ADJUVANT CHEMOTHERAPY; TOTAL MESORECTAL EXCISION; MEDIAN FOLLOW-UP; PREOPERATIVE RADIOTHERAPY; RADIATION-THERAPY; RANDOMIZED-TRIAL; LOCAL EXCISION; CARCINOMA; CHEMORADIOTHERAPY; FLUOROURACIL;

D O I：

10.1007/s11912-013-0362-0

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The role and sequencing of radiotherapy in the management of T3-4 or node- positive rectal cancer has evolved over the last few decades. Given the significant local failure rate following surgery alone, both preoperative and postoperative chemotherapy and radiotherapy have been studied to decrease local and systemic failure and improve survival in these patients. This review discusses current indications and controversies for treatment of stage II-III rectal cancer patients.

引用

页数：9

共 50 条

[21] Organ Preservation in the Treatment of Stage II and III Rectal Cancer
Hagen, Edward R.
Cleary, Robert K.
DISEASES OF THE COLON & RECTUM, 2020, 63 (09) : 1185 - 1189
[22] CLINICAL UTILITY OF POST-CHEMORADIATION THERAPY RESTAGING WITH MRI FOR STAGE II-III RECTAL CANCER PATIENTS.
Aryan, M.
Grajo, J.
Moser, P.
Burriss, N.
George, T.
Hughes, S. J.
Tan, S.
Iqbal, A.
DISEASES OF THE COLON & RECTUM, 2018, 61 (05) : E258 - E259
[23] Lymph node ratio, an independent prognostic factor for patients with stage II-III rectal carcinoma
Fulop, Zsolt Zoltan
Gurzu, Simona
Bara, Tivadar
Dragus, Emoke
Bara, Tivadar, Jr.
Voidazan, Septimiu
Banias, Laura
Jung, Loan
PATHOLOGY RESEARCH AND PRACTICE, 2019, 215 (06)
[24] OUTCOMES PREDICTOR FOR THE PATIENTS WITH STAGE II AND III RECTAL CANCER
Hiranyakas, A.
Yik-Hong, H.
Kirsch, J.
Bashankaev, B.
Rosen, L.
Wexner, S.
DISEASES OF THE COLON & RECTUM, 2010, 53 (04) : 654 - 655
[25] Neoadjuvant combination for stage II-III breast cancer
Bagchi, Sanjit
LANCET ONCOLOGY, 2007, 8 (07): : 579 - 579
[26] Role of adjuvant chemotherapy in patients with stage II-III ampullary cancer.
Semenov, Nikolay
Zhukova, Lyudmila
Grechukhina, Katerina
Izrailov, Roman
Dalgatov, Kamil
Khatkov, Igor
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 508 - 508
[27] Genetic Variant Associated With Survival of Patients With Stage II-III Colon Cancer
Penney, Kathryn L.
Banbury, Barbara L.
Bien, Stephanie
Harrison, Tabitha A.
Hua, Xinwei
Phipps, Amanda I.
Sun, Wei
Song, Mingyang
Joshi, Amit D.
Alberts, Steven R.
Allegra, Carmen J.
Atkins, James
Colangelo, Linda H.
George, Thomas J.
Goldberg, Richard M.
Lucas, Peter C.
Nair, Suresh G.
Shi, Qian
Sinicrope, Frank A.
Wolmark, Norman
Yothers, Greg
Peters, Ulrike
Newcomb, Polly A.
Chan, Andrew T.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 18 (12) : 2717 - +
[28] Efficacy of Definitive Radiotherapy for Stage II-III Cervical Cancer in Elderly Patients
Li, Huiling
Lin, Xian
Chen, Wenjuan
Xie, Rong
Chen, Guilin
INTERNATIONAL JOURNAL OF GERONTOLOGY, 2024, 18 (01) : 42 - 47
[29] PROGNOSTIC FACTORS FOR PATIENTS WITH RECURRENT DISEASE IN STAGE II-III COLON CANCER
Mateo, Joaquin
Lopez-Doriga, Adriana
Navarro, Matilde
Martinez Villacampa, M. Mercedes
Laquente, Berta
Soler, Gemma
Ramos, Emilio
Biondo, Sebastiano
Macia, Ivan
Salazar, Ramon
Santos, Cristina
ANNALS OF ONCOLOGY, 2011, 22 : v107 - v107
[30] Novel Model to Predict the Prognosis of Patients with Stage II-III Colon Cancer
Xu, Yansong
Liang, Fangfang
Chen, Yi
Wang, Zhen
Zhong, Huage
Tang, Weizhong
BIOMED RESEARCH INTERNATIONAL, 2020, 2020

← 1 2 3 4 5 →